[Paget's disease, workup and monitoring]
- PMID: 15962503
- DOI: 10.1016/s0755-4982(05)83990-9
[Paget's disease, workup and monitoring]
Abstract
Paget's disease is a progressive bone disease, characterized by bone hypertrophy and increased bone resorption. The pain and deformity that characterize its clinical course are not simple to assess, but it has a characteristic radiographic appearance. In most cases, treatment can be monitored through biological markers of bone turnover. Total alkaline phosphatase is the best marker and measurement of collagen breakdown products is useful in difficult cases. The goal of treatment is the normalization of these biological markers, to prevent complications of the disease.
Similar articles
-
Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.Arthritis Rheum. 1997 Mar;40(3):461-8. doi: 10.1002/art.1780400312. Arthritis Rheum. 1997. PMID: 9082934
-
Biochemical assessment of Paget's disease of bone.J Bone Miner Res. 2006 Dec;21 Suppl 2:P22-7. doi: 10.1359/jbmr.06s204. J Bone Miner Res. 2006. PMID: 17229003 Review.
-
Absence of anatomic arteriovenous shunts in Paget's disease of bone.N Engl J Med. 1972 Oct 5;287(14):686-9. doi: 10.1056/NEJM197210052871403. N Engl J Med. 1972. PMID: 5055417 No abstract available.
-
[Use of biochemical markers of bone turnover in Paget's disease of bone].Ann Biol Clin (Paris). 2001 May-Jun;59(3):309-11. Ann Biol Clin (Paris). 2001. PMID: 11397680 French. No abstract available.
-
Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.Wien Med Wochenschr. 2017 Feb;167(1-2):18-24. doi: 10.1007/s10354-016-0502-x. Epub 2016 Sep 6. Wien Med Wochenschr. 2017. PMID: 27600563 Review. English.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical